SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology

BACKGROUND: Statins have anti-inflammatory and immunomodulatory properties in addition to their lipid-lowering effects. Currently, the effects of statins on multiple sclerosis are still controversial. Therefore, randomized clinical trials are needed to provide better evidence on the therapeutic pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamm, Christian P, Mattle, Heinrich P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801665/
https://www.ncbi.nlm.nih.gov/pubmed/20003436
http://dx.doi.org/10.1186/1745-6215-10-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801665/
https://www.ncbi.nlm.nih.gov/pubmed/20003436
http://dx.doi.org/10.1186/1745-6215-10-115

Ejemplares similares